Is Bafna Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Bafna Pharmaceuticals Ltd (BAFNAPH.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Bafna Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bafna Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Bafna Pharmaceuticals Ltd?

Muslim investors may consider investing in Bafna Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bafna Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Bafna Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bafna Pharmaceuticals Ltd updated?

The Shariah compliance status of Bafna Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bafna Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bafna Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Bafna Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Bafna Pharmaceuticals Ltd BAFNAPH.NS

₹135.30 ₹0.30 (0.22%) 1D

Last Updated: May 15, 12:00 AM·NSE

BAFNAPH.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 16, 2026

Report Source: 2026 3rd Quarter Report

Bafna Pharmaceuticals Ltd. Stock Analysis BAFNAPH.NS

India Health Care Nano Cap Report: Q3, 2026

Bafna Pharmaceuticals Ltd. engages in the manufacture of drugs and medicines of life saving drugs. The company is headquartered in Chennai, Tamil Nadu and currently employs 406 full-time employees. The company went IPO on 2008-06-27. The firm exports its products to the Europe, the United Kingdom, Australia, Sri Lanka, Africa, and Commonwealth countries.

Key Statistics of Bafna Pharmaceuticals Ltd (BAFNAPH.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹135.00₹141.60

Today's Open

₹135.00

Volume

1101.00

P/E Ratio (TTM)

78.65

52 Week Range

₹72.01₹202.06

Market Cap

3.24B

Avg. Volume

2739.77

Dividend Yield

Financial Metrics & Statements of Bafna Pharmaceuticals Ltd (BAFNAPH.NS)

FAQ's for Bafna Pharmaceuticals Ltd (BAFNAPH.NS)

According to Musaffa’s Shariah screening methodology, Bafna Pharmaceuticals Ltd (BAFNAPH.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.